Aldagen: Clinical Trials

7 trials sponsored by Aldagen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated, 1 unknown, 1 withdrawn. 4 Phase 1, 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Withdrawn 1
Phase 23Completed 2, Unknown 1
Phase 31Terminated 1

Follow Aldagen: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Patients With Intermittent Claudication Injected With ALDH Bright Cells
ALD-301, Placebo (vehicle) - Peripheral Artery Disease, Intermittent Claudication
Phase 2CompletedThe University of Texas Health Science Center, Houston822013-06-012017-04-21
Study of ALD-401 Via Intracarotid Infusion in Ischemic Stroke Subjects
ALD-401, Sham Procedure - Stroke, Ischemic Stroke
Phase 2UnknownAldagen1002011-03-012014-01-16
Fetal Umbilical Cord Blood (UCB) Transplant for Lysosomal Storage Diseases
ALD-601 - Lysosomal Storage Diseases, Inborn Errors of Metabolism
Phase 1WithdrawnJoanne Kurtzberg, MD2009-10-012017-06-29
ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases
ALD-101 - Inherited Metabolic Diseases, Lysosomal Storage Disorders
Phase 3TerminatedAldagen402008-03-012014-07-08
ALD-301 for Critical Limb Ischemia, Randomized Trial
ALDH-br bone marrow cells vs. mononuclear bone marrow cells - Critical Limb Ischemia, Peripheral Arterial Disease
Phase 1 / Phase 2CompletedAldagen202006-10-012009-05-14
Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br)
Stem Cell Therapy, Control (plasma) - Coronary Artery Disease
Phase 1CompletedTexas Heart Institute212006-04-012024-04-23
Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells
ALDHbr Umbilical Cord Blood Cells - MDS, Anemia, Aplastic
Phase 1CompletedJoanne Kurtzberg, MD372005-10-012017-06-29

Conditions studied

Metabolism, Inborn Errors (3)  ·  Ischemia (2)  ·  Lysosomal Storage Diseases (2)  ·  Mucopolysaccharidosis I (2)  ·  Mucopolysaccharidosis II (2)  ·  Peripheral Arterial Disease (2)  ·  Adrenoleukodystrophy (1)  ·  Anemia, Aplastic (1)  ·  Canavan Disease (1)  ·  Chronic Limb-Threatening Ischemia (1)  ·  Coronary Artery Disease (1)  ·  Fucosidosis (1)  ·  Gangliosidoses, GM2 (1)  ·  Gangliosidosis, GM1 (1)  ·  Hematologic Neoplasms (1)

Interventions

Serum Albumin, Human (1)

Countries

United States (7)

Top investigators

Joanne Kurtzberg, MD (3)  ·  Emerson C Perin, M.D., Ph.D. (1)  ·  Emerson Perin, MD, PhD (1)  ·  Farrell Mendelsohn, MD (1)  ·  James Hinson, MD (1)  ·  James M Hinson, MD (1)  ·  Michael Murphy, MD (1)  ·  Nicolas Chronos, MD (1)  ·  Robert Mitchell, MD (1)  ·  Robert Simari, MD (1)

Results publications

PMID 21594960, PMID 28209728, PMID 30586746

NIH funding

UM1HL087318-06 (1)